Nakagama H - Search Results

1

Stemness and immune evasion conferred by the TDO2-AHR pathway are associated with liver metastasis of colon cancer.

Miyazaki T, Chung S, Sakai H, Ohata H, Obata Y, Shiokawa D, Mizoguchi Y, Kubo T, Ichikawa H, Taniguchi H, Aoki K, Soga T, Nakagama H, Okamoto K. Miyazaki T, et al. Among authors: nakagama h. Cancer Sci. 2022 Jan;113(1):170-181. doi: 10.1111/cas.15182. Epub 2021 Dec 2. Cancer Sci. 2022. PMID: 34714577 Free PMC article.

2

Parp-1 deficiency implicated in colon and liver tumorigenesis induced by azoxymethane.

Nozaki T, Fujihara H, Watanabe M, Tsutsumi M, Nakamoto K, Kusuoka O, Kamada N, Suzuki H, Nakagama H, Sugimura T, Masutani M. Nozaki T, et al. Among authors: nakagama h. Cancer Sci. 2003 Jun;94(6):497-500. doi: 10.1111/j.1349-7006.2003.tb01472.x. Cancer Sci. 2003. PMID: 12824873 Free article.

3

Modeling human colon cancer in rodents using a food-borne carcinogen, PhIP.

Nakagama H, Nakanishi M, Ochiai M. Nakagama H, et al. Cancer Sci. 2005 Oct;96(10):627-36. doi: 10.1111/j.1349-7006.2005.00107.x. Cancer Sci. 2005. PMID: 16232193 Free article. Review.

4

Inhibition of peroxisome proliferator-activated receptor gamma activity suppresses pancreatic cancer cell motility.

Nakajima A, Tomimoto A, Fujita K, Sugiyama M, Takahashi H, Ikeda I, Hosono K, Endo H, Yoneda K, Iida H, Inamori M, Kubota K, Saito S, Nakajima N, Wada K, Nagashima Y, Nakagama H. Nakajima A, et al. Among authors: nakagama h. Cancer Sci. 2008 Oct;99(10):1892-900. doi: 10.1111/j.1349-7006.2008.00904.x. Cancer Sci. 2008. PMID: 19016747 Free article.

5

Cytoplasmic tethering is involved in synergistic inhibition of p53 by Mdmx and Mdm2.

Ohtsubo C, Shiokawa D, Kodama M, Gaiddon C, Nakagama H, Jochemsen AG, Taya Y, Okamoto K. Ohtsubo C, et al. Among authors: nakagama h. Cancer Sci. 2009 Jul;100(7):1291-9. doi: 10.1111/j.1349-7006.2009.01180.x. Epub 2009 Apr 27. Cancer Sci. 2009. PMID: 19432880 Free article.

6

Mdmx enhances p53 ubiquitination by altering the substrate preference of the Mdm2 ubiquitin ligase.

Okamoto K, Taya Y, Nakagama H. Okamoto K, et al. Among authors: nakagama h. FEBS Lett. 2009 Sep 3;583(17):2710-4. doi: 10.1016/j.febslet.2009.07.021. Epub 2009 Jul 18. FEBS Lett. 2009. PMID: 19619542 Free article.

7

Functional screening using a microRNA virus library and microarrays: a new high-throughput assay to identify tumor-suppressive microRNAs.

Izumiya M, Okamoto K, Tsuchiya N, Nakagama H. Izumiya M, et al. Among authors: nakagama h. Carcinogenesis. 2010 Aug;31(8):1354-9. doi: 10.1093/carcin/bgq112. Epub 2010 Jun 4. Carcinogenesis. 2010. PMID: 20525881

8

Tumor suppressor miR-22 determines p53-dependent cellular fate through post-transcriptional regulation of p21.

Tsuchiya N, Izumiya M, Ogata-Kawata H, Okamoto K, Fujiwara Y, Nakai M, Okabe A, Schetter AJ, Bowman ED, Midorikawa Y, Sugiyama Y, Aburatani H, Harris CC, Nakagama H. Tsuchiya N, et al. Among authors: nakagama h. Cancer Res. 2011 Jul 1;71(13):4628-39. doi: 10.1158/0008-5472.CAN-10-2475. Epub 2011 May 12. Cancer Res. 2011. PMID: 21565979 Free PMC article.

9

Systematic exploration of cancer-associated microRNA through functional screening assays.

Izumiya M, Tsuchiya N, Okamoto K, Nakagama H. Izumiya M, et al. Among authors: nakagama h. Cancer Sci. 2011 Sep;102(9):1615-21. doi: 10.1111/j.1349-7006.2011.02007.x. Epub 2011 Jul 12. Cancer Sci. 2011. PMID: 21668585 Free article. Review.

10

Differential expression of nanog1 and nanogp8 in colon cancer cells.

Ishiguro T, Sato A, Ohata H, Sakai H, Nakagama H, Okamoto K. Ishiguro T, et al. Among authors: nakagama h. Biochem Biophys Res Commun. 2012 Feb 10;418(2):199-204. doi: 10.1016/j.bbrc.2011.10.123. Epub 2011 Oct 31. Biochem Biophys Res Commun. 2012. PMID: 22079639

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

285 results

Search Page